Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.21
+0.20 (0.80%)
At close: Mar 28, 2025, 4:00 PM
25.13
-0.08 (-0.34%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Pfizer stock have an average target of 31.92, with a low estimate of 25 and a high estimate of 45. The average target predicts an increase of 26.62% from the current stock price of 25.21.
Analyst Consensus: Buy
* Price targets were last updated on Feb 5, 2025.
Analyst Ratings
The average analyst rating for Pfizer stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 7 | 8 | 8 | 8 | 8 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +30.90% | Feb 10, 2025 |
| UBS | UBS | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +11.07% | Feb 5, 2025 |
| Citigroup | Citigroup | Hold Maintains $30 → $29 | Hold | Maintains | $30 → $29 | +15.03% | Jan 28, 2025 |
Financial Forecast
Revenue This Year
63.67B
from 63.63B
Increased by 0.06%
Revenue Next Year
63.75B
from 63.67B
Increased by 0.13%
EPS This Year
2.99
from 1.41
Increased by 111.63%
EPS Next Year
3.08
from 2.99
Increased by 3.15%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.8B | 68.4B | 69.0B | ||
| Avg | 63.7B | 63.7B | 62.8B | ||
| Low | 60.8B | 60.1B | 58.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.6% | 7.5% | 8.3% | ||
| Avg | 0.1% | 0.1% | -1.4% | ||
| Low | -4.4% | -5.6% | -8.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.27 | 3.40 | 3.57 | ||
| Avg | 2.99 | 3.08 | 3.07 | ||
| Low | 2.80 | 2.58 | 2.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 131.3% | 13.9% | 15.8% | ||
| Avg | 111.6% | 3.1% | -0.5% | ||
| Low | 98.6% | -13.8% | -18.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.